Suppr超能文献

各种维生素K形式的结构与生物活性之间的关系。

Relationship between Structure and Biological Activity of Various Vitamin K Forms.

作者信息

Bus Katarzyna, Szterk Arkadiusz

机构信息

Department of Spectrometric Methods, National Medicines Institute, 30/34 Chełmska, 00-725 Warsaw, Poland.

Center for Translational Medicine, Warsaw University of Life Sciences, Nowoursynowska 100, 02-797 Warsaw, Poland.

出版信息

Foods. 2021 Dec 17;10(12):3136. doi: 10.3390/foods10123136.

Abstract

Vitamin K is involved many biological processes, such as the regulation of blood coagulation, prevention of vascular calcification, bone metabolism and modulation of cell proliferation. Menaquinones (MK) and phylloquinone vary in biological activity, showing different bioavailability, half-life and transport mechanisms. Vitamin K1 and MK-4 remain present in the plasma for 8-24 h, whereas long-chain menaquinones can be detected up to 96 h after administration. Geometric structure is also an important factor that conditions their properties. -phylloquinone shows nearly no biological activity. An equivalent study for menaquinone is not available. The effective dose to decrease uncarboxylated osteocalcin was six times lower for MK-7 than for MK-4. Similarly, MK-7 affected blood coagulation system at dose three to four times lower than vitamin K1. Both vitamin K1 and MK-7 inhibited the decline in bone mineral density, however benefits for the occurrence of cardiovascular diseases have been observed only for long-chain menaquinones. There are currently no guidelines for the recommended doses and forms of vitamin K in the prevention of osteoporosis, atherosclerosis and other cardiovascular disorders. Due to the presence of isomers with unknown biological properties in some dietary supplements, quality and safety of that products may be questioned.

摘要

维生素K参与许多生物过程,如血液凝固调节、血管钙化预防、骨代谢以及细胞增殖调控。甲萘醌(MK)和叶绿醌的生物活性不同,表现出不同的生物利用度、半衰期和转运机制。维生素K1和MK-4在血浆中的存在时间为8 - 24小时,而长链甲萘醌在给药后96小时仍可被检测到。几何结构也是影响其性质的一个重要因素。-叶绿醌几乎没有生物活性。目前尚无关于甲萘醌的等效研究。降低未羧化骨钙素的有效剂量,MK-7比MK-4低六倍。同样,MK-7对血液凝固系统产生影响的剂量比维生素K1低三到四倍。维生素K1和MK-7都能抑制骨矿物质密度的下降,然而,仅在长链甲萘醌中观察到对心血管疾病发生的益处。目前在预防骨质疏松症、动脉粥样硬化和其他心血管疾病方面,尚无关于维生素K推荐剂量和形式的指南。由于某些膳食补充剂中存在生物特性未知的异构体,这些产品的质量和安全性可能会受到质疑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723a/8701896/fa757ccc2ce5/foods-10-03136-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验